Effectiveness of bnt162b2 variant infection among children 5-11 years of age israel aharona glatman-freedman yael hershkovitz rita dichtiar we assessed effectiveness of the bnt162b2 infection with the b.1.1.529 (omicron) variant (mostly ba.1 subvariant) among children 5-11 years of age in israel

HIGHLIGHTS

• who: Vaccine against Omicron and colleagues from the Aviv University have published the article: Effectiveness of BNT162b2 Variant Infection among Children 5-11 Years of Age Israel Aharona Glatman-Freedman Yael Hershkovitz Rita Dichtiar We assessed effectiveness of the BNT162b2 infection with the B.1.1.529 (Omicron) variant (mostly BA.1 subvariant) among children 5-11 years of age in Israel, in the Journal: (JOURNAL) of November/22,/2021
• what: The authors evaluated BNT162b2 vaccine effectiveness (VE) against SARS-CoV-2 infection among Israeli children 5-11 years of age during the Omicronpredominant period . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.